CLINICAL_TRIALS ClinicalTrials.gov record update

A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00668148
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:52.018203+00:00
Published At: 2018-07-17T00:00:00+00:00
Record Updated At: 2018-07-17
Results Posted At: 2018-07-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ewing\u0027s Sarcoma /Peripheral Neuroectodermal Tumor (PNET)", "Rhabdomyosarcoma", "Leiomyosarcoma", "Adipocytic Sarcoma", "Synovial Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-17"
protocolSection.identificationModule.nctId: "NCT00668148"
protocolSection.identificationModule.officialTitle: "A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing\u0027s Sarcoma/PNET"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-07-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.